Project Details
| Status | Active |
|---|---|
| Effective start/end date | 06/10/21 → … |
PRV-031-003: A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR NonBinding, Anti-C03 Monoclonal Antibody, in Children and Adolescents with Recent-Onset Type
Project: Research